The dopamine transporter (DAT) is one of the most relevant and investigated neurotransmitter transporters. DAT is a plasma membrane protein which plays a homeostatic role, controlling both extracellular and intracellular concentrations of dopamine (DA). Since unbalanced DA levels are known to be involved in numerous mental disorders, a wealth of investigations has provided valuable insights concerning DAT role into normal brain functioning and pathological processes. Briefly, this extensive but non-systematic review discusses what is recently known about the role of SLC6A3 gene which encodes the dopamine transporter in psychiatric phenotypes.
In recent years, excellent reviews have been made about the structure, function, and regulation of DAT and the SLC6 family, describing evidences that support the disruption of these mechanisms in psychiatric and mental disease etiologies (Broer & Gether, 2012; Kristensen et al., 2011; McHugh & Buckley, 2015; Pramod et al., 2013; Rudnick et al., 2014; Schmitt & Reith, 2010; Vaughan & Foster, 2013) .
The main goal of this review is to present what is recently known about the role of DAT gene in psychiatric phenotypes. First, we will briefly describe both DAT protein and gene characteristics. The following sessions will focus on new DAT findings from animal models, neuropsychology, neuroimaging, and psychiatric disorders.
| THE DOPAMINE TRANSPORTER
All knowledge about the structure of human DAT (hDAT) is based on data obtained from studies of other homologous transporters (Cheng & Bahar, 2015; Grouleff, Ladefoged, Koldsø, & Schiott, 2015; Manepalli, Surratt, Madura, & Nolan, 2012) . The first crystal structure of NTT was published in 2005 by Yamashita et al. This study detailed the structure of the bacterial leucine transporter (LeuT) from Aquifexaeolicus, a thermophilic bacterium common to undersea volcanic vents (Yamashita, Singh, Kawate, Jin, & Gouaux, 2005) . The
LeuT consists of 12 transmembrane α-helixes (TMs), with intracellular N-and C-termini, six extracellular and five intracellular loops (EL1-6 and IL1-5), and a substrate binding site (S1) in the transmembrane part of the protein, near two sodium ion binding sites (Yamashita et al., 2005) . Three glycosylation sites are located within the second extracellular loop and these sites appear to be critical for stable membrane expression and transport efficiency of the DAT (Li et al., 2004) . The structure of the first 10 TMs revealed an inverted repeat between TM1-TM5 and TM6-TM10, known as the LeuT-fold Yamashita et al., 2005) .
Another site (S2) in the outside vestibule was observed and it seems to bind to different types of molecules, such as antidepressants and some inhibitors (Singh, Piscitelli, Yamashita, & Gouaux, 2008; Singh, Yamashita, & Gouaux, 2007; Zhen & Reith, 2016; Zhou et al., 2007 Zhou et al., , 2009 ). There are evidences that a second substrate in S2 is needed for triggering the first substrate release from S1 to the intracellular environment Shan, Javitch, Shi, & Weinstein, 2011) . The LeuT crystal structure has enabled computational studies, resulting in a huge leap in knowledge of MATs and some homology models of hDAT have been created (Beuming et al., 2008; Grouleff et al., 2015; Koldsø, Christiansen, Sinning, & Schiott, 2013; Loland, 2015) . Recently, the first high-resolution structure of a eukaryotic MAT was published. Penmatsa, Wang, and Gouaux (2013) reported the DAT crystal structure from Drosophila melanogaster (dDAT) which provides new possibilities for eukaryotic transporters studies. Large similarity was observed between the crystal structure of dDAT and the homology model of hDAT constructed based on LeuT, although the TM2 of dDAT seems to be slightly kinked . A cDNA sequence has predicted hDAT protein with 620 amino acids almost identical in size to the rat DAT cDNA (Vandenbergh, Persico, & Uhl, 1992) . The hDAT amino acids sequence within the transmembrane domains showed 97% of identity with the rat transporter cDNA and this conservation is higher than 87% conservation in regions outside the membrane (Vandenbergh et al., 1992) .
The main function of DAT is to regulate DA availability in the synapse. DAT removes DA from the synaptic cleft back inside the presynaptic neuron where it can be re-packaged into new vesicles for a re-release, terminating the DA actions on its corresponding receptors and limiting its effects (Brooks, 2016) . Moreover, the DAT seems to have a low norepinephrine (NE) affinity (Broer & Gether, 2012; Koldsø et al., 2013) . As a member of the SLC6 family, DAT depends on the energy from coupling the energetically favorable movement of Na + and Cl − for the thermodynamically unfavorable flux of substrate into the cell (Kristensen et al., 2011; Rudnick et al., 2014) . This proposed mechanism follows the 1:2:1 proportion for dopamine, Na + , and Cl − , respectively (Broer & Gether, 2012) . Accordingly, the gradient of sodium which is maintained by the sodium/potassium ATPase pump has an important role in this process because the electrochemical potential in these ion gradients is used by DAT to accumulate intracellular DA in higher concentrations than outside the cell (Kristensen et al., 2011; Rudnick et al., 2014) .
The DAT is expressed in all dopamine neurons, including those in the substantia nigra and ventral tegmental area (Ciliax et al., 1999) .
However, DAT density is higher in the striatum and nucleus accumbens, where it is the major regulator of dopamine signaling (Brooks, 2016) . The density of DAT in the frontal areas is lower when compared to NET which is effective as NE or DA carrier (Madras, Miller, & Fischman, 2005) . Similar to other membrane proteins, DAT seems not to be randomly distributed in the plasma membrane but associated with plasma membrane microdomains called lipid rafts (Adkins et al., 2007; Hong & Amara, 2010; Vaughan & Foster, 2013) .
Lipid rafts are cholesterol-and sphingolipid-rich microdomains which compartmentalize cellular processes, organizing centers for the assembly of signaling molecules and ensuring appropriate spatial and temporal regulation of transporter function in the presynaptic membrane (Rudnick et al., 2014; Vaughan & Foster, 2013) . Rudnick et al. (2014) highlighted that the knowledge of appropriated membrane microdomain localization of transporters may identify new mechanisms to influence synaptic transmission. In fact, raft partition seems to have significant consequences for DAT regulation (Rudnick et al., 2014; Vaughan & Foster, 2013) . Moreover, DAT seems to be regulated by N-and C-terminal tails into the cytoplasm of dopaminergic neurons because these regions contain sites for binding-partner interactions, post-translational modifications, and regulatory motifs (for review of regulation mechanisms of DAT, see Vaughan & Foster, 2013) .
| GENE STRUCTURE
The DAT protein is coded by SLC6A3 gene (or DAT1) which spans >60 kb and is located in human chromosome 5 (5p15.3) (Haddley et al., 2008; Vandenbergh et al., 1992) . The SLC6A3 contains 15 exons separated by 14 introns, and the protein-coding portion excludes exon 1 and ends near the beginning of exon 15. A single transcription start site (TSS) was observed, and computational analyses have indicated alternative splicing of transcripts (Bannon, Michelhaugh, Wang, & Sacchetti, 2001; Shumay, Fowler, & Volkow, 2010; Talkowski et al., 2010) . A cassette exon within intron 3 (E3b) was observed in postmortem human substantia nigra (Talkowski et al., 2010) . Moreover, Fox-2 binding sites were found in SLC6A3, suggesting regulatory elements for alternative splicing, considering that Fox-2 family is formed by regulators of neuron-specific splicing pattern (Shumay et al., 2010) .
Two possible polyadenylation sites were identified in the 3′ untranslated region (3′-UTR) based on the cDNA sequence, even though the use of these sites is not clear in the literature (Kawarai, Kawakami, Yamamura, & Nakamura, 1997) .
The promoter region of the human SLC6A3 gene is unique. Neither a canonical "TATA" box, nor a "CAT" box was found (Shumay et al., 2010) . However, several CCAAT elements upstream and downstream of SLC6A3 TSS were observed (Shumay et al., 2010) . The transcriptional initiation from CCAAT consensus involves selective transcription factors, because NF-Y (a histone-like element) interacts with them (Shumay et al., 2010) . The human SLC6A3 gene is remarkably GC-rich and has multiple CpG islands Shumay et al., 2010) .
Although the presence of CpG islands in the promoter region is usual among genes, 80% of SLC6A3 promoter is formed by GCs sequences and more than 20 CpG islands were observed (Shumay et al., 2010) .
Therefore, the SLC6A3 gene is highly sensitivity to epigenetic regulation mechanisms.
hDAT is expressed specifically in dopaminergic neurons. However, the characteristics of the SLC6A3 promoter appear not to lead to neurospecificity, suggesting that silencing elements would be necessary to adequate DAT expression (Kouzmenko, Pereira, & Singh, 1997; Sacchetti, Brownschidle, Granneman, & Bannon, 1999) . There are evidences of putative silencing domains within intron 1 and 5′-flanking sequence of the gene that could act in concert to silence the SLC6A3 promoter in non-neuronal cells as well as in non-DA neurons . Moreover, enhancer elements also seem to play a role in SLC6A3 expression regulation (Greenwood & Kelsoe, 2003) . Several evidences have shown that nuclear receptor nurr1 enhances the transcriptional activity of SLC6A3 gene that is important for the maintenance of functional midbrain DA neurons (Kadkhodaei et al., 2009; Sacchetti, Mitchell, Granneman, & Bannon, 2001 ).
Several analyses revealed that conserved sequences of SLC6A3 are specific to coding regions while 5′-flanking region, 3′-UTR, and introns are not conserved (Grunhage et al., 2000; Shumay et al., 2010) . These evidences suggest that individual SLC6A3 differences must arise primarily from regulatory sequences Shumay et al., 2010) . Multiple variants are mapped to the SLC6A3 locus: rare variants, copy number variations (CNVs), variable number of tandem repeats (VNTRs), and several single nucleotide polymorphisms (SNPs). There are several SNPs across this gene, highlighting −839C/T (rs2652511) and −67A/T (rs2975226) SNPs located in the promoter region which were associated with some psychiatric disorders (Genro et al., 2007 (Genro et al., , 2008 Huang et al., 2010; Huang, Lu, ShihC, Yen, & Huang, 2013; Huang et al., 2015; Xu et al., 2009 Mao, 1995) . Several functional studies have focused on the effect of this polymorphism in SLC6A3 expression changes (Faraone, Spencer, Madras, Zhang-James, & Biederman, 2014; Fuke et al., 2001 Fuke et al., , 2006 Kanno & Ishiura, 2011; Lynch et al., 2003; Martinez et al., 2001; Michelhaugh, Fiskerstrand, Lovejoy, Bannon, & Quinn, 2001; Mill, Asherson, Browes, D'Souza, & Craig, 2002; Miller & Madras, 2002; Tai et al., 2016; van Dyck et al., 2005; VanNess, Owens, & Kilts, 2005) . The strongly controversial results concluded that the SLC6A3 3′-UTR VNTR may not have a significant functional effect on DAT expression and that this polymorphism needs to be analyzed in haplotypes with other genetic variants (Greenwood & Kelsoe, 2003; McHugh & Buckley, 2015) . Based on the analyses of several polymorphisms across SLC6A3, the gene structure revealed the presence of haplotype blocks, mainly in the 5′ and 3′ regions, suggesting that these regions are functionally distinct (Brookes et al., 2006; Friedel et al., 2007; Genro et al., 2008; Greenwood & Kelsoe, 2003; Greenwood, Schork, Eskin, & Kelsoe, 2006) . In fact, haplotype blocks across the SLC6A3 gene seem to affect DAT expression.
Association results from different populations have shown an important role of these haplotypes in psychiatric disorders (Friedel et al., 2007; Greenwood & Kelsoe, 2003; Genro et al., 2008; Greenwood et al., 2006) . Therefore, the LD structure of SLC6A3 gene should be considered for genetic studies with SLC6A3.
| ANIMAL MODELS
Deficiency of DAT gene in mice is one of the best examples of animal genetic models. Numerous other animal models with altered DAT function were created, including strains with deficient DAT expression, modified DAT gene knock-in and DAT gene over-expression (Efimova, Gainetdinov, Budygin, & Sotnikova, 2016) . These mutants are extremely valuable to investigate the effects of pharmacological action of psychostimulants and compounds potentially active in counteracting consequences of dopaminergic dysfunction (Gainetdinov, 2008) . In addition, these mice have provided models of major endophenotypes of human diseases, such as attention-deficit/ hyperactivity disorder (ADHD; Gainetdinov, 2008; Leo & Gainetdinov, 2013) .
Homologous recombination in vivo has been used to create DAT knockout mice or DAT-KO mice strains (Efimova et al., 2016) .
Homozygous mice for this mutation are more prone to premature death (almost 70% of animals survived after 10 weeks) and they gain weight more gradually than heterozygous and wild-type mice (Bosse et al., 1997; Giros, Jaber, Jones, Wightman, & Caron, 1996) . Moreover, mutant homozygous females have impaired maternal behavior (Giros SALATINO-OLIVEIRA ET AL.
| 213 et al., 1996) . DAT-KO mice have certain behavioral phenotypes, such as hyperlocomotion, disrupted sensorimotor gating, increased impulsivity, and impaired ability to perform learning tasks (Efimova et al., 2016) . When exposed to novel environments, DAT-KO mice present spontaneous hyperlocomotion despite main adaptive changes (Efimova et al., 2016; Giros et al., 1996) . This increase in spontaneous locomotion in the absence of DAT could be explained by the extended length of time that DA spends in the extracellular space following release (Giros et al., 1996) . DAT-KO mice also showed deficits in both short-term spatial working memory and spatial cognitive performance, supporting the modulation of cognitive flexibility by dopamine (Dzirasa et al., 2009; Li, Arime, Hall, Uhl, & Sora, 2010; Morice et al., 2007) .
DAT-KO mice have exhibited a severe impairment in cliff avoidance reaction (CAR) compared to wild-type mice and treatment with methylphenidate (MPH) ameliorated CAR impairments (Yamashita et al., 2013) .
DAT-KO animals exhibit behaviors considered to be deeply related to some psychiatric disorders. Behaviors of DAT-KO mice mimic positive symptoms of schizophrenia (SCZ) (Gainetdinov, Mohn, & Caron, 2001 ). Abnormalities of neurons dendritic spines observed in postmortem studies of SCZ patients' brains were also shown in DAT-KO mice (Efimova et al., 2016; Kasahara, Arime, Hall, Uhl, & Sora, 2015) . However, DATdeficient mice may not reproduce the full spectrum of schizophrenia-related behaviors, such as those related to social interactions (Gainetdinov et al., 2001) . Pregnenolone which is used as an alternative drug in SCZ treatment was effective to rescue schizophrenia-like symptoms of these mutant mice (Wong et al., 2012; Wong, Sze, Chang, Lee, & Zhang, 2015) .
Moreover, the sensorimotor deficits of DAT-KO mice could be reversed by clozapine and quetiapine administration, two antipsychotics used in SCZ and bipolar disorder treatments (Powell, Young, Ong, Caron, & Geyer, 2008) . Taking into account that evidences have also indicated reduced DAT expression in bipolar disorder, DAT knockdown (DAT-KD) mice exhibit a wide range of mania-like behaviors-hyperactivity, increased exploration, impulsivity, and more predictable and repetitive locomotor patterns (Logan & McClung, 2016; Perry et al., 2009; van Enkhuizen, Geyer, & Young, 2013; van Enkhuizen, Geyer, Halberstadt, Zhuang, & Young, 2014; Young, van Enkhuizen, Winstanley, & Geyer, 2011) .
The DAT deficient mice seem also to be a valuable model for ADHD, mainly when hyperactivity and impulsivity symptoms, and cognitive deficits are considered (Efimova et al., 2016; Leo & Gainetdinov, 2013) . Methylphenidate (MPH) and amphetamine (AMPH), two stimulants largely used in ADHD treatment, reduce hyperactivity in DAT-KO animals (Gainetdinov, Jones, & Caron, 1999) .
Moreover, the administration of serotonin transporter inhibitors of serotonin receptor agonists and antagonists also decreases hyperactivity in these mutants (Barr et al., 2004; Beaulieu, Sotnikova, Gainetdinov, & Caron, 2006; Gainetdinov et al., 1999) . Although NET inhibitors administration did not reduce hyperactivity, the impulsivity might be ameliorated in the cliff avoidance reaction test (Gainetdinov et al., 1999; Yamashita et al., 2013 Expression modifications of DAT by genetic or epigenetic variation were also associated with impulsive behaviors in nonhuman primates, Rhesus (Macacamulatta) and Capuchins (Cebusapella) monkeys respectively (Lucarelli et al., 2017; Rajala et al., 2014) . Therefore, nonhuman primates may also be useful animal models for neurodevelopmental disorder investigations (Phillips et al., 2010) .
| NEUROPSYCHOLOGICAL AND NEUROIMAGING INVESTIGATIONS
Levels of dopamine in high density regions of DAT depend on the activity of its transporter. DAT is abundant in the striatum and midbrain which are brain areas engaged in working memory (WM), for instance, defined as the capacity to store and manipulate information for a brief period of time (Hazy, Frank, & O'Reilly, 2006) . Therefore, investigations of DAT binding or how DAT expression variation affects performance on neuropsychological tasks and brain functionality are very valuable to understand neuropsychiatric disorders.
Zilles et al. (2012) found a better visuospatial WM performance in 9R carriers compared to 10R homozygotes in the 3′-UTR SLC6A3
VNTR in a mixed sample of SCZ, bipolar I disorder, obsessivecompulsive disorder, and healthy adults. In that study, SLC6A3 effects were independent from diagnoses. On the other hand, the SLC6A33′-UTR VNTR seems not to predict performance in spatial WM task in a sample of healthy individuals (Blanchard, Chamberlain, Roiser, Robbins, & Muller, 2011; Wonodi et al., 2009 ). Individual differences in the efficiency of updating stimulus-response episodes were also affected by repeat variations of the 3′-UTR VNTR, reflecting the efficiency of the striatal dopaminergic pathway in adults (Colzato et al., 2013) . The performance of 9R carriers was more affected by stimulusresponse bindings than 10/10 homozygotes (Colzato, Zmigrod, & Hommel, 2013) . SLC6A3 variation effect was also investigated in WM plasticity by WM training, including verbal and visuospatial tasks, in a sample of 29 young adults (Brehmer et al., 2009 ). The 3′-UTR VNTR 9R allele carriers showed a tendency for greater training-related gains than 10R homozygotes in visuospatial WM, but these results need to be replicated in a larger sample (Brehmer et al., 2009 ). The SLC6A3 gene was not associated with bistable perception in healthy adult individuals (Schmack et al., 2013) . This measure tests the rate of spontaneous and automatic alternation between two perceptual stages when visual information is ambiguous. In a recent meta-analysis, the results suggested that the SLC6A3 3′-UTR VNTR was not a significant predictor of cognitive function in healthy adults (Ettinger, Merten, & Kambeitz, 2016) . Bipolar disorder patients showed slower perceptual switching and this has been suggested as a trait marker for this disease (Eysenck, 1952; Krug, Brunskill, Scarna, Goodwin, & Parker, 2008; Miller et al., 2003; Nagamine, Yoshino, Miyazaki, Takahashi, & Nomura, 2009; Philip, 1953; Pettigrew & Miller, 1998) . In children, the rs27072T allele located in the SLC6A3 3′-UTR was associated with training gains during cognitive training in children (Söderqvist et al., 2012) . However, several SNPs were analyzed in that study and the p values are uncorrected for multiple comparisons (Söderqvist et al., 2012) . The haplotype G-C-C-G (rs4036-rs463379-rs393795-rs37020) was associated with decreased spatial WM in children with ADHD in a Taiwanese sample (Shang & Gau, 2014) .
In typically developing children, functional anatomy mediating WM was changed by SLC6A3 3′-UTR VNTR according to the processing load (Stollstorff et al., 2010) . The 10R homozygotes were liable to reduced performance and lack of basal ganglia involvement under higher WM requirements (Stollstorff et al., 2010) . In the same way, this SLC6A3 genetic variant seems to affect brain activation and connectivity during WM updating across adult life span (Sambataro et al., 2015 ). An investigation about the possible relationship of No differences of DAT binding between cases and controls were observed in a sample of children with autism (Makkonen, Riikonen, Kokki, Airaksinen, & Kuikka, 2008; McDougle, 2008) . In another study, DAT binding was significantly increased in the medial region of the orbitofrontal cortex in adults with autism (Nakamura et al., 2010) .
However, more work is needed to clarify if DAT availability in autistic adults is associated to behaviors related to orbitofrontal circuit as impulsivity and aggressiveness (Nakamura et al., 2010) .
Few investigators have examined DAT binding in suicide attempters. No association between DAT differences and suicide was disclosed (Desmyter, van Heeringen, & Audenaert, 2011; Fitzgerald et al., 2017) . Significantly lower DAT binding rates were found in striatum, caudate, and putamen in depressed patients with or without anhedonia compared to healthy individuals (Camardese et al., 2014) . The authors suggested that the functionality of the striatal dopaminergic system is decreased in depression disorder as a whole (Camardese et al., 2014) . A meta-analysis of molecular imaging studies has concluded that there is no evidence for alteration of striatal DAT availability in major depression (Li et al., 2015) . Nonetheless, significant heterogeneity and potential interference of confounding factors were found in this meta-analysis (Li et al., 2015) . In schizophrenic patients, although the DAT level in the striatum was normal, an excess of striatal DA was prominent in the rostral caudate (Kegeles et al., 2010) . Higher DAT in the thalamus but not in substantia nigrahas been shown (Arakawa et al., 2009 ). Nevertheless, this study needs to be interpreted with caution because the sample size was small and the binding potential relative to the non-displaceable compartment (BPND) was low (Arakawa et al., 2009; Weinstein et al., 2017) . No evidence of alteration in DAT density of striatal terminals in SCZ were disclosed in meta-analysis (Fusar-Poli & Meyer-Lindenberg, 2013) .
In 2014, a meta-analysis was performed including positron emission tomography (PET) and single-photon emission computed tomography (SPECT) assessing DAT availability in the human brain in healthy subjects and psychiatric patients (Faraone et al., 2014) . PET studies indicated that the 9R allele significantly increases DAT binding in the striatal brain regions independent of the presence of psychiatric disorders (Faraone et al., 2014) . However, SPECT data were tightly heterogeneous due to methodological differences (Faraone et al., 2014) . The inferior frontal-anterior/posterior cingulate-thalamuscaudate and the default mode-fronto-temporal gyrus were correlated to SLC6A3 3′-UTR VNTR in SCZ patients, by parallel independent component analysis (Meda et al., 2010) . A higher left amygdala reactivity was found in subjects carrying at least one 9R allele than carriers of two 10R alleles in two samples of different populations:
social anxiety disorder subjects from Sweden, and healthy volunteers from United States (Bergman et al., 2014) . Furthermore, these results
were not influenced by diagnostic categories (Bergman et al., 2014) .
Recent findings suggested that SLC6A3 gene variation is associated with structural differences in both the right lateral prefrontal cortex (PFC) and the cingulate cortex among ADHD patients. Brain Magnetic
Resonance Imaging (MRI) revealed greater cortical thickness in right cingulate cortex as well as decreased cortical thickness in right lateral PFC in ADHD children and adolescents homozygous for the 10R allele comparing to 9R carriers (Fernandéz-Jaén et al., 2015 . These results corroborate previous imaging genetic studies that examined the effect of SLC6A3 genotypes on striatum and PFC (Brown et al., 2010; Bédard et al., 2010; Braet et al., 2011; Durston et al., 2005; Shook et al., 2011) . Caudate volumes were smaller in 10R/10R than 9R/10R children with or without ADHD although this genetic variant did not vary by ADHD diagnosis (Shook et al., 2011) . However, ADHD children had smaller caudate volume than controls (Shook et al., 2011) . ADHD adult carriers of SLC6A3 9R-6R haplotype of the International Multicentre persistent ADHD CollaboraTion (IMpACT) showed 5.9% larger striatum volume than participants not carrying this haplotype (Onnink et al., 2016 ). An Interesting study compared the availability of DAT using single-photon emission computed tomography (SPECT) between healthy subjects with and without ADHD offspring (Tai et al., 2016) . The DAT availability in healthy parents with ADHD offspring was lower in basal ganglia, caudate nucleus, and putamen than controls without ADHD offspring (Tai et al., 2016 
| PSYCHIATRIC DISORDERS AND DOPAMINE TRANSPORTER
The number of significant and non-significant studies is shown in Figure 1 , and the main findings of the association among psychiatry disorders and DAT gene polymorphisms are summarized in Table 1 .
| Addictive disorders
Addictive disorders, such as substance abuse and dependence, are common disorders that involve the overuse of alcohol or drugs.
Addiction develops over time and is a chronic and relapsing illness (American Psychiatric Association, 2013). Cocaine and amphetamines interact with DAT directly. Whereas tobacco and alcohol do not influence DAT function directly, they may mediate modifications in dopamine levels indirectly (Zhu & Reith, 2008) . Nevertheless most genetic investigations addressed these last two drugs.
Cocaine is a potent and highly addictive drug and its effects in behaviors seem to be mainly through DAT blockage, increasing substantially DA concentration in synapses (Verma, 2015) . This increase in extracellular DA results in elevated stimulation of neurons in brain areas involved in reward and reinforcement behavior (Verma, 2015) .
Haplotype frequencies of SLC6A3 3′-UTR and Intron 8 VNTRs were not associated with cocaine addiction in a Spanish case-control study (Fernàndez-Castillo et al., 2010) . Moreover, among 37 genes related to serotonin and dopamine transmission and neurotrophic factors, SLC6A3 gene was not associated with cocaine dependence in the same population (Fernàndez-Castillo et al., 2013) . In Brazilian samples, SLC6A3 gene variants were associated with cocaine abuse and crack-cocaine abuse and dependence (Guindalini et al., 2006; Stolf et al., 2014) . The 3R allele of intron eight VNTR was associated with cocaine abuse and haplotype associations with the outcome were due to this VNTR variation (Guindalini et al., 2006) . Moreover, functional analyses showed a reduced expression of DAT protein in the presence of the 3R allele (Guindalini et al., 2006) . On the other hand, the 10R/ 10R genotype of the 3′-UTR VNTR showed an increased frequency in cases of crack cocaine abusers or dependents compared to controls (Stolf et al., 2014) . More investigations should be performed to confirm and clarify the DAT contribution in crack-cocaine dependence (Stolf et al., 2014) . Subjective responses to cocaine are modulated by SLC6A3
gene variability among individuals with cocaine use disorders (Brewer et al., 2015) . Subjects with 10R/10R genotype at 3′-UTR VNTR and 5R
allele at Intron 8 VNTR showed decreased subjective responses to acute cocaine compared with their counterparts (Brewer et al., 2015) .
In a population of African ancestry, no statistically significant differences of allele or genotype frequencies were observed between cocaine-dependent individuals and controls for SLC6A3 3′-UTR VNTR.
One study investigated the correlation between SLC6A3 polymorphisms and DAT mRNAs in postmortem ventral midbrain in a casecontrol sample of cocaine abusers of an African American population (Zhou et al., 2014) . DAT activity variation appeared to be attributed to both genetics and cocaine abuse, and the possible interaction between these factors could be through epigenetic effects in SLC6A3 (Zhou et al., 2014) .
Amphetamine and methamphetamine are two major amphetamine-like drugs that predominantly release monoamine including serotonin, norepinephrine, and dopamine by reverse transport of dopamine through the DAT (Sulzer, Sonders, Poulsen, & Galli, 2005) .
Although amphetamine has comparable effects in neurons containing monoamines, it is the action of dopamine that is mainly implicated in amphetamine-induced reinforcing and reward. Considerable effort has been devoted toward understanding mechanisms whereby amphetamines and its analogs affect monoaminergic neuronal function. In vivo and in vitro studies provided critical understanding of the physiological and pathological processes associated with monoaminergic function and regulation (Fleckenstein, Volz, Riddle, Gibb, & Hanson, 2007; Zhu & Reith, 2008) ; however, the role of genetic markers in individual susceptibility to these stimulants are scarce. Two investigations in Alcohol-dependence (AD) in one of the most prevalent psychiatric disorders and its heritability is estimated to be from 50% to 70% in both men and women (Goldman, Oroszi, & Ducci, 2005; Pagan et al., 2006) . This disorder may be classified into type 1 (without antisocial personality disorder and with late onset) and type 2 (with antisocial personality disorder and with early onset; Irwin, Schuckit, & Smith, 1990 ). In a case-control Brazilian sample, the interactions between the SLC6A3 3′-UTR VNTR and both dopamine receptor D4(DRD4) gene variants and novelty seeking behavior predicted alcohol consumption (Bau et al., 2001 ). However, the interaction effect between SLC6A3
and novelty seeking did not remain significant after Bonferroni correction (Bau et al., 2001) . a German sample (Reese et al., 2010) . Moreover no over-transmission of investigated haplotypes from parents to affected offspring (Reese et al., 2010) was observed. In the other hand, the daily ethanol consumption was associated with homozygous 5-G-9 haplotype in men (Reese et al., 2010) . Nonetheless, in a recent meta-analysis, the SLC6A3 gene was associated with alcohol dependence with an important role in the etiology of this disorder (Ma, Fan, & Li, 2016) .
The 9R allele carriers had more risk to be alcohol dependent than individuals carrying other alleles in the 3′-UTR VNTR (Ma, Fan, & Li, 2016 ).
Higher DAT methylation in peripheral blood leucocytes was observed in alcohol-dependent (AD) patients than in healthy individuals, independently of age (Wiers et al., 2015) . Moreover, DAT methylation was also higher in AD patients with moderate depression scores than AD patients with low depression scores (Wiers et al., 2015) . Nevertheless, the analyses of 23 CpG islands did not show statistical differences on methylation status except for CpG located in position 12, poorly studied in the literature (Jasiewicz et al., 2015) .
Methylation at this position is higher in control subjects than in AD patients (Jasiewicz et al., 2015) . In a review performed by Quaak et al. (2009) , the literature pointed that reduction in DAT levels is related to diminished smoking behaviors, but other studies did not replicate these results (Erblich, Lerman, Self, Diaz, & Bovbjerg, 2004; Jorm et al., 2000; Lerman et al., 1999; Sabol et al., 1999; Vandenbergh et al., 2002) . The low dopamine levels regulated by DAT may also be associated with TS treatment (Quaak et al., 2009) . Moreover, SLC6A3 variants effects seem to be moderated by early heavy or regular tobacco and alcohol use to predict dependence of these substances in young adulthood (Schmid et al., 2009 ). In a sample of smokers aged 12-13 years, no association between SNPs in 24 candidate genes and number of cigarettes or nicotine dependence remained statistically significant after corrections, including rs11737901 at SLC6A3 (O'Loughlin et al., 2014) . In a Mexican Mestizo sample, the SLC6A3 3′-UTR VNTR was not significantly associated with cigarette consumption, smoking duration, and age of initiation (Svyryd et al., 2016) .
In relation to smoking treatment, a recent meta-analysis concluded that SLC6A3 gene variations are not significantly associated with smoking cessation outcome (Duck & Gyoon, 2016) . This result is not consistent with a previous meta-analysis (Stapleton, Sutherland, & O'Gara, 2007) . However, various factors such as age, gender, ethnicity, and environment and genetic interactions should be considered in future analyses. Thereafter, another meta-analysis with Caucasian samples only reported that the 3′VNTR 9R genotypes were significantly associated with the ability to achieve smoking cessation (Ma, Yuan, Cui, & Li, 2016) . A gene score analysis showed significant positive effects between SLC6A3, ankyrin repeat and kinase domain containing 1 (ANKK1), DRD4 gene score and smoking cessation in a rural male population of China . It is important to note that although these inconsistent results, SLC6A3 gene is still an important candidate gene for smoking-related behaviors.
| Attention-deficit/hyperactivity disorder (ADHD)
ADHD is one of the most prevalent mental disorders in childhood, affecting 5.29% of school age children worldwide (Polanczyk, de Lima, Horta, Biederman, & Rohde, 2007; Polanczyk, Willcutt, Salum, Kieling, & Rohde, 2014) . ADHD features include age-inappropriate hyperactivity, impulsivity, and inattention (American Psychiatry Association, 2013). There are controversial evidences about the amount of ADHD symptoms that persists into adulthood. New ADHD trajectories are explored in recent studies (Caye et al., 2016; Moffitt et al., 2015) .
ADHD is considered a very heterogeneous disorder and, even though it is highly heritable, few identified genetic variants explained only a small portion of its heritability (Akutagava-Martins, Salatino-Oliveira, Kieling, Rohde, & Hutz, 2013; Faraone et al., 2005) . It should be noted that the SLC6A3 gene is the most extensively studied loci so far in ADHD (Akutagava-Martins et al., 2013; Franke et al., 2010; Hawi et al., 2015) . Moreover, a recent huge systematic study reported that the SLC6A3 gene is one of twelve genes associated with ADHD (Li, Kapoor, & Manor, 2016) . showed that rs463379 in intron four was associated with ADHD in a sample of German families. Moreover, this SNP with other two SNPs (rs6350-rs403636-rs463379) formed the C-G-C risk haplotype for ADHD (Friedel et al., 2007) . In a Brazilian ADHD sample of children, the rs2652511 polymorphism but not 3′-UTR VNTR was associated with ADHD using family association analyses (Genro et al., 2007) .
When these analyses was extended to 16 polymorphisms across the SLC6A3 gene, a preferential transmission of the haplotype A-C-C-C-A (rs2550948, rs11564750, rs261759, rs2652511, rs2975223) located in the 5′ region was observed in children with DSM-IV ADHD combined subtype (Genro et al., 2008) . Recently the rs11564750 was also associated with the combined ADHD subtype in a case-control study of a children and adolescents sample from Spain (GomezSanchez et al., 2016) . Therefore, the promoter region may be involved in ADHD susceptibility in childhood and allele heterogeneity should be considered in SLC6A3 analyses, highlighting the importance of this gene in ADHD genetics. However, in Taiwanese ADHD probands, the T allele of rs2975226 located in promoter region of SLC6A3 gene was over-transmitted while the rs2652511 was not associated with ADHD (Xu et al., 2009 ). Therefore, due to this heterogeneity, ADHD studies need to consider the whole variability of the SLC6A3 gene.
In the three-replication samples of the International Multi-Centre ADHD Genetics (IMAGE) project, the 6R and 10R alleles from intron SALATINO-OLIVEIRA ET AL.
eight and 3′-UTR VNTRs, respectively, were over-transmitted from parents to ADHD children (Hawi et al., 2010) . Using continuous analyses of ADHD symptom severity in a sample of families from Colorado, the 3′-UTR VNTR 10R allele was associated with a greater risk for ADHD symptoms in children (Bidwell et al., 2011) . However, this association seems to be stronger for inattention symptoms than hyperactivity-impulsivity (Bidwell et al., 2011) . Likewise, the 9R homozygous genotype seems to reduce the risk of ADHD in a sample of Czech children (OR = 0.40) (Šerý et al., 2015) .
Investigations about the effects of both gene x environment (GxE) and gene × gene (GxG) interactions in psychiatric disorders have been identified as of great potential to elucidate the etiology of mental disorders (Duncan & Keller, 2011; Halldorsdottir & Binder, 2017; Zuk, Hechter, Sunyaev, & Lander, 2012) . In family samples from Taiwan and England, both 10R and 3R alleles on 3′-UTR and intron eight VNTRs, respectively, were associated with ADHD (Brookes et al., 2006) .
Moreover, the interaction effect of 10R-3R risk haplotype and maternal use of alcohol during pregnancy was significant in this disorder (Brookes et al., 2006) . A significant effect of the interaction between SLC6A3 gene and maltreatment was observed in girls from the National Longitudinal Study of Adolescent Health (Li & Lee, 2012) .
Maltreated girls who have two copies of the 10R allele had more ADHD symptoms and were more than 2.5 times more likely to be classified as combined ADHD group (Li & Lee, 2012) . Moreover, the investigation of the role of Catechol-o-methyltransferase (COMT) and
SLC6A3 genes on ADHD symptoms in the 1993 Pelotas Birth Cohort
Study revealed that these genes affect hyperactivity/inattention symptoms in boys at ages 11 and 15 years besides predicting ADHD diagnosis at 18 years also in boys . This study suggests that both COMT and SLC6A3 genes are associated with ADHD symptoms in the general population and corroborates previous evidence of sexual dimorphism on SLC6A3 expression (Becker, El-Faddagh, Schmidt, Esser, & Laucht, 2008; Dluzen & McDermott, 2002; Guo, Roettger, & Shih, 2007) .
In a meta-analysis performed by Franke et al. (2010) , the 10R/10R
genotype of the 3′-UTR VNTR and the 10R-6R haplotype (3′-UTR VNTR-intron eight VNTR) seemed to be risk factors for ADHD in children whereas the 9R/9R genotype and the 9R-6R haplotype were associated with adult ADHD. The authors highlighted that the inconsistent results suggest that there is a differential association of SLC6A3 gene with ADHD in children and in adults. In this same dataset from Franke et al. (2010) , there was no evidence for epistatic effect between of the SLC6A3 9R-6R haplotype and the DRD4 L-4R
haplotype (dup120pb L allele-48pb VNTR) in ADHD adults (Sánchez-Mora et al., 2011) .
In a Brazilian sample of adults with ADHD, haplotype analysis of 3′-UTR and Intron 8 VNTRs did not find any association with ADHD, but the Intron 8 VNTR 6R allele was associated with higher inattention scores (de Azeredo et al., 2014) . The 10R-6R haplotype (3′-UTR and intron eight VNTRs) was also associated with the increase of ADHD symptoms in nonclinical adults .In a current metaanalysis, the 9R-6R haplotype was not associated with any trait (Bonvicini, Faraone, & Scassellati, 2016) .
Pharmacotherapy is crucial in ADHD treatment and methylphenidate (MPH) is the most widely used drug (Szobot, Ketzer, Parente, Biederman, & Rohde, 2004; Wilens, 2008) . MPH seems to bind to the catecholaminergic transporters in the presynaptic membrane and blocks the re-uptake of DA, increasing levels of synaptic DA (Berridge et al., 2006; Pliszka, 2005; Solanto, 2002) . Therefore, several investigations focused on the effect of SLC6A3 variants in ADHD treatment with MPH (Bruxel et al., 2014; Contini et al., 2010; Rovaris et al., 2014) . Although SLC6A3 is undoubtedly a candidate gene for MPH pharmacogenetics studies, the literature did not consistently suggest a role for this gene in the improvement of ADHD symptoms across the life-cycle (Bruxel et al., 2014; Kambeitz, Romanos, & Ettinger, 2014) . Methodological differences and the complex architecture of SLC6A3 gene may be considered for future investigations (Bruxel et al., 2014) . Furthermore, recent initial evidences suggest that the effectiveness of MPH treatment in ADHD may be modulated by SLC6A3 epigenetic alterations mainly in the oppositional and hyperactive-impulsive symptoms (Ding et al., 2017) . Therefore, more pharmacogenetic studies using new strategies should be performed to possibly clarify the understanding of individual characteristics of treatment .
| Autism spectrum disorders
Autism spectrum disorder (ASD) is a heterogeneous group of severe complex neurodevelopmental disorders which affects 1-2% of the general population (Evans, 2013) . Children with ASD present increased rates of comorbidities such as ADHD, anxiety and depression (Nguyen et al., 2014) . ASD has a heritability of more than 90% but the genetic background of ASD remains unclear (Freitag, 2007; Zafeiriou, Ververi, Dafoulis, Kalyva, & Vargiami, 2013) . Multiple factors are needed for autism development, including genetic, epigenetic, and environment factors (Yu, Wu, & Wu, 2015) .
Associations of SLC6A3 gene variants with emotion dysregulation, ADHD symptoms, tic disorder, and anxiety symptoms were studied in samples of children with ASD, but the results were conflicting (Gadow, Pinsonneault, Perlman, & Sadee, 2014; Gadow, Roohi, DeVincent, & Hatchwell, 2008) . According to parent ratings, 10R homozygous children showed less severe symptoms of hyperactivity and impulsivity (Gadow et al., 2008) . In another study, the same genotype group showed more severe symptoms of inattention, motor tics, vocal tics, and social anxiety in teacher ratings (Gadow et al., 2008 (Gadow et al., , 2014 .
Moreover, SLC6A3 Intron 8 VNTR was associated with more severe symptoms of parent-rated emotion dysregulation and hyperactivity (Gadow et al., 2014) . However, these findings need to be interpreted with caution since they were not corrected for multiple comparisons nor haplotype analyses were performed.
Some studies have revealed that rare variants in SLC6A3 may contribute to ASD etiology. Recently, sequencing analysis showed the SLC6A3 R/W variant, in one family with two children with ASD, resulting in an Arg to Trp substitution at site 51 (Cartier et al., 2015) .
The SLC6A3 R/W displays inhibited reverse transport of DA without impairments in uptake function (Cartier et al., 2015) . Remarkable, a de novo SLC6A3 T356M variant and a recurrent SLC6A3 A559V variant seen in two boys with ASD were previously found to cause dysregulation of DA efflux (Brown et al., 2010; Hamilton et al., 2013) . Previously, SLC6A3 A559V was also reported in one female with bipolar disorder and in two male siblings with ADHD (Grunhage et al., 2000; Mazei-Robison, Couch, Shelton, Stein, & Blakely, 2005) .
Bioinformatics analyses support the link among genes of dopaminergic system and physiological mechanisms to ASD (Nguyen et al., 2014) .
The DAT was one of the proteins strongly implicated in ASD (Nguyen et al., 2014) . Furthermore, biological interactions among proteins of dopaminergic system and other ASD-associated proteins show the complex regulation of brain functioning (Nguyen et al., 2014) . diagnosed in childhood or in older age (Birmaher et al., 2006; Geller, Tillman, Craney, & Bolhofner, 2004) .
| Bipolar disorder
A current compiled list of recognized genes which are clinically relevant for BPD was placed on high-resolution human chromosome ideograms (Douglas, McGuire, Manzardo, & Butler, 2016) . The genes identified in this analysis impacted a broad range of biological pathways, such as SLC6A3 in the dopaminergic system (Douglas et al., 2016) . Moreover, altered DAT protein and mRNA levels were observed in BD prefrontal cortex (Rao, Kellom, Reese, Rapoport, & Kim, 2012) . The SLC6A3 rs27072 was significantly associated with BPD in two separate cohorts (Pinsonneault et al., 2011) . Further functional analyses found allelic differences in DAT expression in substantia nigra and in vitro, indicating a possible functional role of this SNP in BPD (Pinsonneault et al., 2011) . However, Cosgrove et al. (2012) reported that no evidence of association between SLC6A3 3′-UTR VNTR alleles and BPD in youth was observed.
In children with BPD, some candidate gene studies with SLC6A3
polymorphisms have been performed but presented inconsistent results (Mick & Faraone, 2009 ). BPD and ADHD in children are frequently comorbid conditions, and several studies have indicated a strong overlap between them (Biederman, Newcorn, & Sprich, 1991; Biederman, Russell, Soriano, Wozniak, & Faraone, 1998; Biederman et al., 1996 Biederman et al., , 2013 . The possible relationship of SLC6A3 variants in childhood ADHD features in BPD was explored (Greenwood et al., 2013) . Strong associations between a SLC6A3 variant in intron 8 (rs27048) and ADHD scores were observed in a BPD family sample, a case-control sample, and in a combined analysis (Greenwood et al., 2013) . Tobacco use disorder (TUD) was also studied among BPD adult patients and the risk for this comorbidity was estimated at approximately 2.4 times higher than in the general population (McEachin et al., 2010) . A common underlying genetic etiology between TUD and BPD was tested using multiple bioinformatics resources. In that study, the authors identified a gene network strongly associated with both disorders, including the SLC6A3 gene (McEachin et al., 2010) . In an adult Chinese case-control sample, the promoter G-A-C-G haplotype formed by rs6350-rs2975226-rs2652511-rs6413429 SNPs was over-represented in BPD cases than controls and it was also associated with personality trait vulnerability in BPD patients (Huang et al., 2015) .
| Depression disorders
Depression is a highly prevalent disorder, the lifetime prevalence estimates of this disorder as 11.7% in adolescents and 16.6% in adults (Kessler et al., 2005; Merikangas et al., 2010) . Depression is a serious medical condition and it is projected to be the leading cause of disease burden worldwide by 2030 (World Health Organization, 2008) . The etiology of this disease is complex and several environmental risk factors for depression have been established (Dunn et al., 2015) . The heritability of depression is considered moderate with an estimation of 40% (Rice, Harold, & Thapar, 2002) . Typically, genetic studies of depression have focused on monoaminergic genes because deficiencies in dopamine, serotonin, and norepinephrine systems have been reported in major depressive disorder (MDD) (Dunn et al., 2015; Xia & Yao, 2015) .
In a meta-analysis performed in 2008, the SLC6A3 gene was considered one of the six MDD susceptibility genes and the authors have highlighted that replications are needed and efforts are essential to standardize the methodology in MDD research (López-León et al., 2008) . However, in a recent review the SLC6A3 gene did not show evidence of significant association in the published GWAS of depression (Dunn et al., 2015) . A rare duplication spanning more than 100 genes in addition to SLC6A3 was found in a patient with MDD in the Copenhagen High-Risk study (Hoeffding et al., 2016) . Furthermore, one pharmacogenetics study reported that SLC6A3 3′-UTR VNTR influences rapid response to antidepressant therapy in a naturalistic prospective cohort (Kirchheiner et al., 2007) .The 9R allele homozygous carriers showed a poorer response to all types of antidepressants compared to 10R
carriers (Kirchheiner et al., 2007) .
GxE analyses suggested that SLC6A3 SNPs may interact with perinatal factors to influence depressive symptoms (D'Souza et al., 2016; Haeffel et al., 2008) . The interaction effect of rs40184 SNP and maternal rejection was associated with MDD onset in adolescents, as well as on suicidal ideation (Haeffel et al., 2008) . Individuals who suffered maternal rejection and had the rs40184TT genotype were more likely to have an episode of depression (Haeffel et al., 2008) . In a Thai sample, the SLC6A3rs40184SNP was not associated with MDD (Pattarachotanant, Sritharathikhun, Suttirat, & Tencomnao, 2010 Analyses of the SLC6A3 effect in personality traits in patients with major depression showed no association among 17 SNPs and tridimensional personality questionnaire in a Han Chinese sample of patients with MDD (Huang, Lu, Shih, Yen, & Huang, 2011) . The casecontrol analyses also did not confirm a role for SLC6A3 in the susceptibility to major depression (Huang et al., 2011) . In the same population, rs2550948 GG genotype and rs2975226 TT genotype were associated with lower novelty seeking scores in early onset MDD patients than their counterparts (Huang et al., 2013) . The SLC6A3 3′-UTR VNTR was associated with borderline personality disorder which is often comorbid with MDD (Joyce et al., 2006) . The 9R allele was considered a genetic risk factor for borderline personality disorder in MDD patients in two samples (Joyce et al., 2006) . Further investigations are required to verify the effects of SLC6A3 in personality traits in MDD.
Theory of mind (ToM) is a theory of how observable behaviors of others are linked with internal mental states (Wellman, 1990) .
Recently, ToM was associated with SLC6A3 3′-UTR VNTR in depressed young adults (Zahavi et al., 2016) . This human skill has been shown in disorders with social dysfunction, such as MDD (Lee, Harkness, Sabbagh, & Jacobson, 2005) . The 10R homozygous group had an inferior accuracy in decoding mental states of a positive valence while this same group had a superior accuracy in decoding mental states of a negative valence (Zahavi et al., 2016) . However, more studies are needed to clarify if the role of SLC6A3 in the ToM decoding skill.
| SCHIZOPHRENIA
The theory of DA involvement in schizophrenia (SCZ) was formulated in 1966, by Rossum et al. Initially, an excess of dopaminergic stimulation was proposed in patients with SCZ (van Rossum, 1966) .
Later, this hypothesis was defined by D2 receptor (DRD2) binding profiles of antipsychotics and DA agonist effects (Carlsson, 1978; Lieberman, Kane, & Alvir, 1987; Seeman, Lee, Chau-Wong, & Wong, 1976) . Recent findings have suggested that there is an imbalance between DAT excess and deficit in subcortical and cortical areas, respectively, with some variations (Kennedy et al., 2016; Markota, Sin, Pantazopoulos, Jonilionis, & Berretta, 2014; Weinstein et al., 2017) .
SLC6A3 gene has been associated with established SCZ endophenotypes (Greenwood et al., 2016; Wonodi et al., 2009 ). Smooth pursuit eye movement (SPEM) deficits was associated with SLC6A3 3′-UTR VNTR variants (Wonodi et al., 2009) . The 10R/10R genotype was associated with worse SPEM in schizophrenic patients (Wonodi et al., 2009 (Talkowski et al., 2008) . Moreover, the authors performed functional analyses and they noted plausible allele-specific functional effects in vitro for rs3756450 SLC6A3 SNP in the 5′ upstream region (Talkowski et al., 2008) . Two SLC6A3 SNPs (rs2652511 and rs2975226) and a promoter region haplotype (rs2652511, rs2975226, and rs6413429) were associated with SCZ in a Han Chinese sample (Huang et al., 2010) . However, these polymorphisms did not affect the severity of psychotic symptoms (Huang et al., 2010) . Haplotype analyses have also found an association between G-C (rs2975223-rs2455391) haplotype and increased risk for SCZ in the Chinese population (Zheng, Shen, & Xu, 2012) . However, in another investigation, association of other SLC6A3 six SNPs in SLC6A3 with SCZ were analyzed in the Han
Chinese population but no significant associations were observed (Yang et al., 2014) .
A deletion covering more than 40 genes including SLC6A3 was identified in a patient with SCZ from a Danish sample (Hoeffding et al., 2016) . No CNVs were found in healthy controls, suggesting a role for DAT rare variants in SCZ (Hoeffding et al., 2016) . These findings are in agreement with current results which showed a higher frequency of protein-compromising rare variants in individuals with SCZ (Genovese et al., 2016) . These rare variants were concentrated in exons of brain- 
| CONCLUSION AND PERSPECTIVES
The present review concludes that DAT research is highly relevant for the understanding of normal brain functioning and brain developmental disorders. The use of animal models hassignificantly increased this knowledge and several progresses in gene editing technologies may support new models to use DAT mutants on cognitive aspects of DA abnormalities (Efimova et al., 2016) . Moreover, imaging studies also have strived to understand the role of DAT in brain functionality although the lack of PET investigations and the reported heterogeneity of findings across SPECT studies are a challenge for definite conclusions (Faraone et al., 2014) . In addition, functional in vitro studies of SLC6A3 gene have achieved interesting results but they are still conflicting (Faraone et al., 2014) . Overall, these findings remain complex and further investigations are needed to clarify the connections among SLC6A3 variants, DAT binding, and the function- However, it is crucial to note that if some genetic factors are associated with an endophenotype, they do not are necessarily involved in a specific psychiatric disorder etiology. Additionally, the majority of SLC6A3 studies are focused on 3′-UTR SLC6A3 VNTR.
Nonetheless, if SLC6A3 gene haplotype blocks seem to affect DAT expression, future studies need to consider multiple variants or the sequence as a whole in different populations (Faraone et al., 2014; Friedel et al., 2007; Genro et al., 2008; Greenwood & Kelsoe, 2003; Greenwood et al., 2006; Shumay et al., 2010) . For example, other regions of SLC6A3 gene besides the VNTRs might also be crucial for ADHD in different populations (Friedel et al., 2007; Genro et al., 2007 Genro et al., , 2008 Genro, Kieling, Rohde, & Hutz, 2010; Gomez-Sanchez et al., 2016) . Therefore, studies focusing on common and rare variants, considering SLC6A3 linkage disequilibrium structure in different populations, might be necessary to elucidate the molecular mechanisms by which SLC6A3 variants contribute to diverse psychiatric disorders.
Although the high sensitivity for epigenetic regulation is the most noteworthy characteristic of the human SLC6A3 gene, there is a lack of epigenetic investigations of this gene. Methylation is the best characterized epigenetic mechanism and the entire SLC6A3 locus has a sequence composition full of CG and comprises multiple CpG islands (Shumay et al., 2010) . Furthermore, GxE and GxG studies may be very helpful to understand psychiatric disorders. An individual carrying a given risk genotype for some psychiatric disorders may interact with different environmental factors or other genetic variants to develop a given phenotype (Cross-Disorder Group of the Psychiatric Genomics Consortium, 2013; Lee et al., 2013) .
Altogether, there are relationships between DAT and the aforementioned psychiatric disorders. Nonetheless, further studies are required to elucidate these relationships. The knowledge of SLC6A3 gene in psychiatric disorders would be better understood if this gene was carefully placed in a context of phenotypic heterogeneity, allelic heterogeneity, and both genetic and environmental interactions. Undoubtedly, it is a huge and complex scenario and the efforts should be driven to draw on this direction.
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